Dog Recombinant GM-CSF (from E. coli)
Vial, 20 µg
Catalog # 77753-272
Supplier: VWR International
Jump to:
- Item requires temperature control for storage and delivery with additional fees. It's not eligible for return due to safety and quality concerns. Consider requirements before purchasing.
- Return Policy
Product Details & Documents
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic growth factor produced by endothelial cells, monocytes, fibroblasts, and T cells. GM-CSF stimulates the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells. GM-CSF promotes immune system development and regulates neutrophil function during infection.
High quality
- Low endotoxin
- Affordable
Caution: For research use only.
Specifications
Specifications
- Type de conditionnement:Vial
- Taille:20 µg
- Protease-free:N
- Purity:≥95%
- Source:E. coli
- Molecular weight:14.4 kDa
- Nuclease-free:N
- Protein/peptide type:Recombinant
- Endotoxin content:Endotoxin LAL (EU/µg) ≤0.1
- Gene ID:P48749
- Formulation:10 mM Sodium phosphate, pH 7.5
- Endotoxin-free:N
- Tested applications:Bioassay
- Species:Dog
- Protein/peptide name:GM-CSF
- Protein synonyms:CSF-2|Pluripoietin-α|MGI-1GM
- Protein Function:Cytokine
- Endotoxin level:Low
- Grade:RUO
- Sequence:MAPTRSPTLV TRPSQHVDAI QEALSLLNNS NDVTAVMNKA VKVVSEVFDP EGPTCLETRL QLYKEGLQGS LTSLKNPLTM MANHYKQHCP PTPESPCATQ NINFKSFKEN LKDFLFNIPF DCWKPVKK
- Biological activity:Bioactivity assay: TF-1 cell proliferation; ED₅₀ ≤15 ng/ml; Bioactivity ≥6.7×10⁴ units/mg
- Shipping temperature:RT
- Cat. No.:77753-272
- Reconstitution instructions:Sterile water at 0.1 mg/ml
- Storage conditions:−20 °C
- Carrier-free:Y
- Conjugation:Unconjugated
- Animal-free:Y
Specifications
Recommendations
Recommendations will be personalized based on your shopping preferences only if you have given your consent by enabling "Enhance my Shopping Experience" on the "Personal Info page".
Otherwise, you will receive generic recommendations.



